AstraZeneca
The aim of this study is to provide the first results on the use of tezepelumab under clinical practice conditions in severe asthma patients who participated in the "foreign medication supply" program in Spain.
Severe Asthma
Study Type : | OBSERVATIONAL |
Estimated Enrollment : | 33 participants |
Official Title : | Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain |
Actual Study Start Date : | 2024-06-17 |
Estimated Primary Completion Date : | 2024-10-25 |
Estimated Study Completion Date : | 2024-10-25 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 12 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Research Site
Alcazar of San Juan, Spain,
Not yet recruiting
Research Site
Almeria, Spain,
Not yet recruiting
Research Site
Badajoz, Spain,
Not yet recruiting
Research Site
Bilbao, Spain,
Not yet recruiting
Research Site
Coslada, Spain,
Not yet recruiting
Research Site
Fuenlabrada, Spain,
Not yet recruiting
Research Site
Gran Canaria, Spain,
Not yet recruiting
Research Site
Lugo, Spain,
Not yet recruiting
Research Site
Madrid, Spain,
Not yet recruiting
Research Site
Malaga, Spain,
Not yet recruiting
Research Site
San Sebastián, Spain,
Not yet recruiting
Research Site
Talavera de la Reina, Spain,
Not yet recruiting
Research Site
Torrejon de Ardoz, Spain,
Not yet recruiting
Research Site
Valencia, Spain,